So, the purpose of the study is to investigate the efficiency of Rood's approach on oxaliplatin-induced peripheral neuropathy in colorectal cancer patients.
Age
18–60
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
The patient can participate in the study if they had at least one cycle of oxaliplatin chemotherapy.
Colorectal cancer patients who have oxaliplatin-induced peripheral neuropathy, the patients included in the study with mild to moderate neuropathy according to mTNS.
Patients from both genders.
Their ages range from 18 to 60 years old.
You may not be if
Patients who had a history of any other neuropathy as diabetic neuropathy.
Patients with an unstable medical condition during chemotherapy.
Patients who are starting new therapy or dose modification during the study period.
Patients with morbid obesity "body mass index \>40%".
Patients with a history of non-surgically repaired nerve compression injuries such as carpal tunnel, brachial plexopathy, spinal stenosis, and spinal nerve root compression.
Patients with a history of central nervous system primary or metastatic malignancy.
